ursolic acid has been researched along with sorafenib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, JC; Hung, HY; Hwang, TL; Kuo, DH; Kuo, PC; Lee, EJ; Nian, CW; Tai, SH; Wu, TS | 1 |
| Fan, L; Jiang, K; Li, T; Shao, J; Zhao, R; Zheng, G | 1 |
| Huang, X; Law, BYK; Li, H; Li, W; Liu, Y; Luo, Z; Yu, Y; Zheng, Y | 1 |
3 other study(ies) available for ursolic acid and sorafenib
| Article | Year |
|---|---|
Chemical Constituents and Anti-inflammatory Principles from the Fruits of Forsythia suspensa.
Topics: Anti-Inflammatory Agents; Diterpenes; Forsythia; Fruit; Humans; Lignans; Molecular Structure; Neutrophils; Pancreatic Elastase; Superoxides; Taiwan | 2017 |
Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Delayed-Action Preparations; Disaccharides; Drug Synergism; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Lung Neoplasms; Male; Mice; Nanoparticles; Niacinamide; Phenylurea Compounds; Porosity; Rats; Silicon Dioxide; Sorafenib; Triterpenes; Ursolic Acid | 2017 |
Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer.
Topics: Amino Acid Transport System y+; Apoptosis; Cell Line, Tumor; Ferroptosis; Humans; Neoplasms; Sorafenib; Triterpenes; Ursolic Acid | 2022 |